The patho-mechanism of somatic driver mutations in cancer usually involves transcription, but the proportion of mutations and wild-type alleles transcribed from DNA to RNA is largely unknown. We systematically compared the variant allele frequencies of recurrently mutated genes in DNA and RNA sequencing data of 246 acute myeloid leukaemia (AML) patients. We observed that 95% of all detected variants were transcribed while the rest were not detectable in RNA sequencing with a minimum read-depth cut-off (10x). Our analysis focusing on 11 genes harbouring recurring mutations demonstrated allelic imbalance (AI) in most patients. GATA2, RUNX1, TET2, SRSF2, IDH2, PTPN11, WT1, NPM1 and CEBPA showed significant AIs. While the effect size was small ...
Advances in sequencing technologies are giving unprecedented insights into the spectrum of somatic m...
Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cas...
Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cas...
The patho-mechanism of somatic driver mutations in cancer usually involves transcription, but the pr...
Acute myeloid leukemia (AML) is characterized by molecular heterogeneity. As commonly altered genomi...
Genetic lesions are crucial for cancer initiation. Recently, whole genome sequencing, using next gen...
In recent years, our understanding of the molecular pathogenesis of myeloid neoplasms, including acu...
BACKGROUND: Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are u...
Genetic heterogeneity contributes to clinical outcome and progression of most tumors, but little is ...
The analyses carried out using 2 different bioinformatics pipelines (SomaticSniper and MuTect) on th...
Acquired genetic aberrations are the underlying cause of leukemogenesis in acute myeloid leukemia (A...
The analyses carried out using 2 different bioinformatics pipelines (SomaticSniper and MuTect) on th...
Myeloid malignancies, including acute myeloid leukaemia (AML), arise from the expansion of haematopo...
The GATA2 gene encodes a zinc-finger transcription factor that acts as a master regulator of normal ...
Advances in sequencing technologies are giving unprecedented insights into the spectrum of somatic m...
Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cas...
Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cas...
The patho-mechanism of somatic driver mutations in cancer usually involves transcription, but the pr...
Acute myeloid leukemia (AML) is characterized by molecular heterogeneity. As commonly altered genomi...
Genetic lesions are crucial for cancer initiation. Recently, whole genome sequencing, using next gen...
In recent years, our understanding of the molecular pathogenesis of myeloid neoplasms, including acu...
BACKGROUND: Many mutations that contribute to the pathogenesis of acute myeloid leukemia (AML) are u...
Genetic heterogeneity contributes to clinical outcome and progression of most tumors, but little is ...
The analyses carried out using 2 different bioinformatics pipelines (SomaticSniper and MuTect) on th...
Acquired genetic aberrations are the underlying cause of leukemogenesis in acute myeloid leukemia (A...
The analyses carried out using 2 different bioinformatics pipelines (SomaticSniper and MuTect) on th...
Myeloid malignancies, including acute myeloid leukaemia (AML), arise from the expansion of haematopo...
The GATA2 gene encodes a zinc-finger transcription factor that acts as a master regulator of normal ...
Advances in sequencing technologies are giving unprecedented insights into the spectrum of somatic m...
Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cas...
Acute myeloid leukemia patients with normal cytogenetics (CN-AML) account for almost half of AML cas...